Agios Pharmaceuticals, Inc. (AGIO)

Agios Pharmaceuticals Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Net Income	-412.78	673.73	-352.09	-231.8	1,605
Depreciation & Amortization	5.18	5.65	6.62	8.56	9.24
Stock-Based Compensation	52.55	42.85	44.77	49.3	53.51
Other Adjustments	15.12	-1,092	23.69	-119.1	16.5
Change in Receivables	-6.47	-1.3	-0.6	-1.76	-4.38
Changes in Inventories	-5.3	-8.54	-10.58	-8.49	-
Changes in Accounts Payable	1.75	6.6	-8.73	3.44	1.86
Changes in Accrued Expenses	-1.4	3.69	12.82	-1.62	0.07
Changes in Income Taxes Payable	-0.87	0.87	-	-	-
Changes in Other Operating Activities	-20.74	-21.1	-11.95	-8	-34.37
Operating Cash Flow	-372.98	-389.84	-296.06	-309.48	-407.32
Capital Expenditures	-4.32	-1.69	-1	-4.88	-
Sale of Property, Plant & Equipment	-	0.04	1.33	0.96	-
Purchases of Investments	-641.76	-1,542	-417.93	-1,031	-1,378
Proceeds from Sale of Investments	1,033	818.38	674.68	1,146	829.8
Other Investing Activities	-10	1,089	-17.5	131.78	-5.74
Investing Cash Flow	377.18	363.44	239.58	243.26	1,249
Issuance of Common Stock	8.68	14.44	5.43	2.68	37.3
Repurchase of Common Stock	-	-	-	-	-802.49
Net Common Stock Issued (Repurchased)	8.68	14.44	5.43	2.68	-765.19
Other Financing Activities	-	-	-	-0.33	-0.58
Financing Cash Flow	8.68	14.44	5.43	2.35	-765.77
Net Cash Flow	12.88	-11.96	-51.05	-63.87	75.69
Free Cash Flow	-377.29	-391.53	-297.06	-314.36	-407.32
FCF Margin	-698.33%	-1072.73%	-1107.49%	-2207.58%	-
Free Cash Flow Per Share	-6.51	-6.76	-5.34	-5.74	-6.74
Levered Free Cash Flow	-438.49	659.22	-364.92	-242.79	1,582
Unlevered Free Cash Flow	-496.69	-414	-404.32	-400.04	-401.62

Updated Feb 12, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q